Possible searches include drugs or medicines (by brand, generic ingredient or drug class), diseases, and more.
Eisai and Arena Pharmaceuticals have announced that the FDA has accepted for filing the New Drug Application for an extended release...
The European Medicines Agency (EMA) has accepted for review the marketing authorization application (MAA) for ONO 7643 (anamorelin HCI),...
The FDA has granted approval for Empliciti (elotuzumab), from BMS/Abbvie, in combination with two other therapies to treat people with...
A FREE CME activity: ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’ is now available to complete on EPGonline.org
Go to CME >